Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04853212

The Role of Intestinal Microbiota Dysbiosis in the Development of Spondyloarthritis

The Role of Dysbiosis of Intestinal Microbiota in the Development of Spondyloarthritis

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The primary objective of this case-control study aims to explore the role of bacterium Ruminococcus gnavus (R. gnavus) with intestinal biopsy and faecal sampling in the initiation and the development of spondyloarthritis (SPA) in comparison with health control subjets (patients without chronic disease but have indication to digestive endoscopy).

Detailed description

As secondary objectives, the study aims: * to research the abundance of bacterial strain of R. gnavus in mucosal sampling by biopsy; * to study the interaction between R. gnavus bacterium and mucus from histological sampling; * to correlate the expression of genes of intestinal mucus with the variations of identified microbiota of mucus biopsy; * to study the interaction between bacteria and intestinal epithelial cells during culture; * to demonstrate perturbations of the immune responses by dysbiosis.

Conditions

Interventions

TypeNameDescription
PROCEDUREBiopsyBiopsy during recto-coloscopy

Timeline

Start date
2021-06-14
Primary completion
2026-05-01
Completion
2026-05-01
First posted
2021-04-21
Last updated
2025-03-19

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04853212. Inclusion in this directory is not an endorsement.